Award
NIH Reporter #5R01CA260137-05
Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer
Recipient
Not specified
Award Amount
$464,525.00
Ceiling
$464,525.00
Awarded
February 05, 2026
Identifier
5R01CA260137-05
NIH/NCI awarded a research project to study a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer, focusing on immuno-oncology and pre-clinical therapeutic evaluations.
Description
This is a funded research project awarded by the NIH/NCI focusing on immuno-oncology, specifically targeting immune checkpoint pathways in cancer. The project involves mechanistic studies and pre-clinical therapeutic evaluations.